Novus creatus, UAB

Company age: 7 y. 0 mo.

Update

Company overview

Company name Novus creatus, UAB
Company code 305249916
Registered address Molėtų r. sav., Giedraičiai, Vilniaus g. 20, LT-33274
Registration date 2019-09-12 Company age: 7 y.
Phone Phone
Email Not disclosed (personal)
Website None
Company manager For registered members only Log in
Revenue (2025) 78,476 € -73% History
Profit (2025) 6,400 € -98% History
Share capital 3,400 €
Number of employees 2 History
Managed vehicles 0
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements Late filing
Legal form Private Limited Liability Company
NACE activity Retail sale of pharmaceutical products
Ownership form Private without foreign capital

Download a detailed company report

Make confident decisions with all the information about Novus creatus, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report

Description

This description was generated by artificial intelligence.
Novus creatus, UAB is an operational private limited liability company registered in 2019. It is a private company in the national private non-financial sector, with private ownership, and its governance is described as CEO only. The company is classified as a micro enterprise. Its activity is retail sale of pharmaceutical products (EVRK code G.47.73.00). The registered address is Vilniaus g. 20, Giedraiciai, Moletu r. sav., Utenos apskr. The share capital amounts to EUR 3.4K.

In financial year 2025, the company generated revenue of EUR 78.5K and net profit of EUR 6.4K, with a profit margin of 8.2%. Revenue declined by 72.9% compared with 2024, when turnover was EUR 289.1K and net profit EUR 256.5K. At the end of 2025, equity stood at EUR 29.0K, total assets at EUR 33.0K, and liabilities at EUR 4.0K. The equity ratio was 88.0%.

The company employed an average of 2 people in 2023, 2024 and 2025, and it has also averaged 2 employees so far in 2026.